Recombinant Mycobacterium Bacillus Calmette-Guerin therapeutic (ImmunityBio)

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NameRecombinant Mycobacterium Bacillus Calmette-Guerin therapeutic (ImmunityBio)
Drug Alias Namerecombinant mycobacterium BCG vaccine (ImmunityBio/Northwestern University Feinberg School of Medicine)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunitybio Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunitybio Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A